Transmedics Group Inc (NASDAQ: TMDX) Is Becoming An Interest-Losing Stock With A 2.85% Incline

In the last trading session, 1.54 million Transmedics Group Inc (NASDAQ:TMDX) shares changed hands as the company’s beta touched 1.88. With the company’s per share price at $127.99 changed hands at $3.55 or 2.85% during last session, the market valuation stood at $4.22B. TMDX’s last price was a premium, traded about 2.71% off its 52-week high of $124.52. The share price had its 52-week low at $36.42, which suggests the last value was 71.54% up since then. When we look at Transmedics Group Inc’s average trading volume, we note the 3-month average coming to 877.87K.

Transmedics Group Inc (NASDAQ:TMDX) trade information

Instantly TMDX was in green as seen at the end of in last trading. With action 39.00%, the performance over the past five days has been green. The jump to weekly highs of 129.66 added 2.85% to the stock’s daily price. The company’s shares are showing year-to-date upside of 62.16%, with the 5-day performance at 39.00% in the green. However, in the 30-day time frame, Transmedics Group Inc (NASDAQ:TMDX) is 65.79% up.

Transmedics Group Inc (TMDX) estimates and forecasts

Data shows that the Transmedics Group Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 236.37% over the past 6 months, a 180.52% in annual growth rate that is considerably higher than the industry average of 13.60%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 8.36%. The 2024 estimates are for Transmedics Group Inc earnings to increase by 199.70%.

TMDX Dividends

Transmedics Group Inc is expected to release its next quarterly earnings report in June.